Benefits Plans - Prescription Drug Plan: Drug Plan Updates and New Drug Releases - Drug Reviews

Page last updated: Wednesday, 26-May-2010 20:51:24 EDT

January - February 2003

The following drug considerations were reviewed and determined for formulary inclusion and tier placement by the U-M Pharmaceutical Benefits Advisory Committee in January and February 2003.

Drug Name PDL Class
Altocor Yes Tier 3
Aumentin XR Yes Tier 3
Depo-Testosterone No Tier 3, quantity limit
Hepsera No Tier 2, PA
Lexapro Yes Tier 3, review data in 6 months
Omnicef Yes Tier 2
Suprax Yes Remove from formulary - product discontinued
Vfend No Tier 2, monitor utilization
Xyrem No Tier 2
Zelnorm NO Tier 2, monitor utilization
The University of Michigan in its sole discretion may modify, amend, or terminate the benefits provided with respect to any individual receiving benefits, including active employees, retirees, and their dependents. Although the university has elected to provide these benefits this year, no individual has a vested right to any of the benefits provided. Nothing in these materials gives any individual the right to continued benefits beyond the time the university modifies, amends, or terminates the benefit. Anyone seeking or accepting any of the benefits provided will be deemed to have accepted the terms of the benefits programs and the university's right to modify, amend or terminate them.